Redx Pharma PLC | Ownership
Companies that own Redx Pharma PLC
AXA Investment Managers UK Ltd.
12,286,220
9.71%
-131,116
0.01%
04/13/2018
Aviva Investors Global Services Ltd.
10,392,513
8.22%
-252,303
0%
04/13/2018
Jarvis Investment Management Ltd.
9,972,000
7.88%
-3,000
0.09%
08/01/2018
HSBC Global Asset Management (UK) Ltd.
7,590,000
6%
34,000
0%
08/01/2018
Hargreaves Lansdown Stockbrokers Ltd.
3,034,629
2.4%
-661,371
0%
04/13/2018
Hargreaves Lansdown Asset Management Ltd.
1,972,000
1.56%
233,000
0%
08/01/2018
Rowan Dartington & Co. Ltd. (Broker)
1,476,000
1.17%
-104,000
0.02%
08/01/2018
Tilney Investment Management Services Ltd.
952,000
0.75%
17,000
0%
08/01/2018
Peel Hunt LLP (Market-Maker)
483,000
0.38%
483,000
0.32%
08/01/2018
Alliance Trust Savings Ltd. (Private Banking)
275,000
0.22%
-52,000
0%
08/01/2018
| Address |
Alderley Park
Macclesfield CQ SK10 4TG
United Kingdom
|
|
Employees
|
- |
| Website |
http://redxpharma.com |
| Updated |
07/08/2019 |
| Redx Pharma Plc engages in the discovery and development of proprietary, small molecule therapeutics to address areas of high, unmet medical need, principally in cancer and fibrosis. The company was founded by Neil David Murray, Peter Jackson, Derek Lindsay, and Norman Molyneux on September 7, 2010 and is headquartered in Macclesfield, the United Kingdom. . |
